Literature DB >> 8352114

Assessment of myometrial invasion by endometrial carcinoma: transvaginal sonography vs contrast-enhanced MR imaging.

Y Yamashita1, H Mizutani, M Torashima, M Takahashi, K Miyazaki, H Okamura, H Ushijima, H Ohtake, T Tokunaga.   

Abstract

OBJECTIVE: A prospective study was designed to compare transvaginal sonography with contrast-enhanced MR imaging to determine preoperatively the depth of myometrial invasion in patients with early-stage endometrial carcinoma. SUBJECTS AND METHODS: In 40 patients, findings on transvaginal sonograms, unenhanced T2-weighted MR images, and contrast-enhanced T1-weighted Mr images were compared with histologic findings. The depth of myometrial invasion was classified as stage E (tumor limited to endometrium, n = 12), stage S (superficial invasion: tumor invades up to 50% of the myometrium, n = 15), or stage D (deep invasion: tumor invades more than 50% of the myometrium, n = 13).
RESULTS: Findings on transvaginal sonograms were accurate in 27 of 40 patients (accuracy, 68%); the depth of invasion was overestimated in five patients and underestimated in eight patients. The results of unenhanced T2-weighted MR images were accurate in 27 patients (accuracy, 68%), with four overestimations and nine underestimations. The results of contrast-enhanced T1-weighted MR images were accurate in 34 patients (accuracy, 85%), with five underestimations and one overestimation. In the assessment of each stage of myometrial invasion, the sensitivity and specificity of contrast-enhanced T1-weighted imaging were higher than those of T2-weighted MR imaging and transvaginal sonography. The false-positive diagnoses based on transvaginal sonograms and T2-weighted images, respectively, involved polypoid tumors (n = 4 and 2), distension of the endometrial cavity by pyometra (n = 2 and 1), the presence of myoma (n = 2 and 1), atrophy of the myometrium (n = 1 and 0), and poor tumor/myometrium contrast (n = 0 and 2). On contrast-enhanced MR images, accuracy was influenced only in a case of polypoid tumor, because tumor, endometrial cavity, and myometrium were clearly distinguished and residual myometrium was clearly visualized. With all imaging techniques, false-negative diagnoses were caused mainly by tumors with superficially spreading growth or microscopic invasion. With transvaginal sonography, infiltrative tumor also tended to be understaged (n = 3).
CONCLUSION: Contrast-enhanced MR imaging is significantly superior to transvaginal sonography and unenhanced T2-weighted MR imaging for detecting myometrial invasion.

Entities:  

Mesh:

Year:  1993        PMID: 8352114     DOI: 10.2214/ajr.161.3.8352114

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  12 in total

Review 1.  Management of gynaecological cancers.

Authors:  A Melville; A Eastwood; J Kleijnen; H Kitchener; P Martin-Hirsch; L Nelson
Journal:  Qual Health Care       Date:  1999-12

2.  Differentiation of the various lesions causing an abnormality of the endometrial cavity using MR imaging: emphasis on enhancement patterns on dynamic studies and late contrast-enhanced T1-weighted images.

Authors:  Byung Kwan Park; Bohyun Kim; Jong Min Park; Jeong Ah Ryu; Mi Sung Kim; Duk Soo Bae; Geung Hwan Ahn
Journal:  Eur Radiol       Date:  2006-02-23       Impact factor: 5.315

3.  Local staging of endometrial carcinoma: role of multidetector CT.

Authors:  A C Tsili; C Tsampoulas; N Dalkalitsis; D Stefanou; E Paraskevaidis; S C Efremidis
Journal:  Eur Radiol       Date:  2008-01-04       Impact factor: 5.315

4.  A thickened or indistinct junctional zone on T2-weighted MR images in patients with endometrial carcinoma: pathologic consideration based on microcirculation.

Authors:  Yumiko Oishi Tanaka; Masato Nishida; Hajime Tsunoda; Yoshihito Ichikawa; Yukihisa Saida; Yuji Itai
Journal:  Eur Radiol       Date:  2003-01-25       Impact factor: 5.315

5.  Evaluation of deep myometrial invasion in endometrial cancer patients: is dual-energy CT an option?

Authors:  Stefania Rizzo; Marco Femia; Davide Radice; Maria Del Grande; Dorella Franchi; Daniela Origgi; Valentina Buscarino; Alberto Mauro; Massimo Bellomi
Journal:  Radiol Med       Date:  2017-09-18       Impact factor: 3.469

Review 6.  Progestins in the fertility-sparing treatment and retreatment of patients with primary and recurrent endometrial cancer.

Authors:  Jeong-Yeol Park; Joo-Hyun Nam
Journal:  Oncologist       Date:  2015-02-11

7.  MR imaging in endometrial carcinoma as a diagnostic tool for the prediction of myometrial invasion and lymph node metastasis.

Authors:  Ui Nam Ryoo; Chel Hun Choi; Ji Yeong Yoon; Soo Kyung Noh; Heeseok Kang; Woo Young Kim; Boh Hyun Kim; Tae-Joong Kim; Jeong-Won Lee; Je-Ho Lee; Byoung-Gie Kim; Duk-Soo Bae
Journal:  Cancer Res Treat       Date:  2007-12-31       Impact factor: 4.679

8.  Preoperative selection of endometrial cancer patients at low risk for lymph node metastases: useful criteria for enrollment in clinical trials.

Authors:  Mariam M AlHilli; Andrea Mariani
Journal:  J Gynecol Oncol       Date:  2014-10       Impact factor: 4.401

9.  Comparison of dynamic contrast-enhanced magnetic resonance imaging with T2-weighted imaging for preoperative staging of early endometrial carcinoma.

Authors:  Linfeng Zheng; Sujuan Zheng; Xiaochun Yuan; Xifu Wang; Zhuoli Zhang; Guixiang Zhang
Journal:  Onco Targets Ther       Date:  2015-07-17       Impact factor: 4.147

10.  Management of early stage, high-risk endometrial carcinoma: preoperative and surgical considerations.

Authors:  Sareena Singh; Shandhini Raidoo; Gaetan Pettigrew; Robert Debernardo
Journal:  Obstet Gynecol Int       Date:  2013-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.